High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India
Open Access
- 4 April 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Health Services Research
- Vol. 17 (1), 1-9
- https://doi.org/10.1186/s12913-017-2191-6
Abstract
Pre-diagnosis attrition needs to be addressed urgently if we are to make progress in improving MDR-TB case detection and achieve universal access to MDR-TB care. We report the pre-diagnosis attrition, along with factors associated, and turnaround times related to the diagnostic pathway among patient with presumptive MDR-TB in Bhopal district, central India (2014). Study was conducted under the Revised National Tuberculosis Control Programme setting. It was a retrospective cohort study involving record review of all registered TB cases in Bhopal district that met the presumptive MDR-TB criteria (eligible for DST) in 2014. In quarter 1, Line Probe Assay (LPA) was used if sample was smear/culture positive. Quarter 2 onwards, LPA and Cartridge-based Nucleic Acid Amplification Test (CbNAAT) was used for smear positive and smear negative samples respectively. Pre-diagnosis attrition was defined as failure to undergo DST among patients with presumptive MDR-TB (as defined by the programme). Of 770 patients eligible for DST, 311 underwent DST and 20 patients were diagnosed as having MDR-TB. Pre-diagnosis attrition was 60% (459/770). Among those with pre-diagnosis attrition, 91% (417/459) were not identified as ‘presumptive MDR-TB’ by the programme. TAT [median (IQR)] to undergo DST after eligibility was 4 (0, 10) days. Attrition was more than 40% across all subgroups. Age more than 64 years; those from a medical college; those eligible in quarter 1; patients with presumptive criteria ‘previously treated – recurrent TB’, ‘treatment after loss-to-follow-up’ and ‘previously treated-others’; and patients with extra-pulmonary TB were independent risk factors for not undergoing DST. High pre-diagnosis attrition was contributed by failure to identify and refer patients. Attrition reduced modestly with time and one factor that might have contributed to this was introduction of CbNAAT in quarter 2 of 2014. General health system strengthening which includes improvement in identification/referral and patient tracking with focus on those with higher risk for not undergoing DST is urgently required.Keywords
This publication has 16 references indexed in Scilit:
- MDR-TB screening in a setting with molecular diagnostic techniques: who got tested, who didn't and why?Public Health Action, 2015
- Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in IndiaPLOS ONE, 2015
- India should screen all tuberculosis patients for drug resistant disease at diagnosisBMJ, 2015
- Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, IndiaPLOS ONE, 2014
- Management of previously treated tuberculosis patients in Kalutara district, Sri Lanka: how are we faring?Public Health Action, 2014
- Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, ChinaPLOS ONE, 2014
- Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance dataThe Lancet Infectious Diseases, 2013
- Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in CambodiaPLOS ONE, 2013
- Operational Challenges in Diagnosing Multi-Drug Resistant TB and Initiating Treatment in Andhra Pradesh, IndiaPLOS ONE, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007